S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
Freshworks gets juiced on its AI customer engagement platform
The Battery Metal Nobody Told You About (Ad)
The Dodgers gave Shohei Ohtani $700 million to hit and pitch — but also because he can sell
3 tech outperformers adored by analysts
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
High short interest stocks: this popular trend is re-emerging
Boeing glides past series of setbacks on new flight path
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Fed is set to leave interest rates unchanged while facing speculation about eventual rate cuts
Biden goes into 2024 with the economy getting stronger, but voters feel horrible about it
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
Freshworks gets juiced on its AI customer engagement platform
The Battery Metal Nobody Told You About (Ad)
The Dodgers gave Shohei Ohtani $700 million to hit and pitch — but also because he can sell
3 tech outperformers adored by analysts
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
High short interest stocks: this popular trend is re-emerging
Boeing glides past series of setbacks on new flight path
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Fed is set to leave interest rates unchanged while facing speculation about eventual rate cuts
Biden goes into 2024 with the economy getting stronger, but voters feel horrible about it
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
Freshworks gets juiced on its AI customer engagement platform
The Battery Metal Nobody Told You About (Ad)
The Dodgers gave Shohei Ohtani $700 million to hit and pitch — but also because he can sell
3 tech outperformers adored by analysts
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
High short interest stocks: this popular trend is re-emerging
Boeing glides past series of setbacks on new flight path
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Fed is set to leave interest rates unchanged while facing speculation about eventual rate cuts
Biden goes into 2024 with the economy getting stronger, but voters feel horrible about it
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
Freshworks gets juiced on its AI customer engagement platform
The Battery Metal Nobody Told You About (Ad)
The Dodgers gave Shohei Ohtani $700 million to hit and pitch — but also because he can sell
3 tech outperformers adored by analysts
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
High short interest stocks: this popular trend is re-emerging
Boeing glides past series of setbacks on new flight path
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Fed is set to leave interest rates unchanged while facing speculation about eventual rate cuts
Biden goes into 2024 with the economy getting stronger, but voters feel horrible about it

Shockwave Medical (SWAV) Stock Price, News & Analysis

$174.20
-0.89 (-0.51%)
(As of 12/8/2023 08:58 PM ET)
Compare
Today's Range
$173.40
$176.60
50-Day Range
$160.99
$215.69
52-Week Range
$157.00
$315.95
Volume
378,600 shs
Average Volume
574,356 shs
Market Capitalization
$6.43 billion
P/E Ratio
27.13
Dividend Yield
N/A
Price Target
$263.00

Shockwave Medical MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.80 Rating Score
Upside/​Downside
51.0% Upside
$263.00 Price Target
Short Interest
Healthy
4.36% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.55
Upright™ Environmental Score
News Sentiment
0.44mentions of Shockwave Medical in the last 14 days
Based on 9 Articles This Week
Insider Trading
Selling Shares
$9.10 M Sold Last Quarter
Proj. Earnings Growth
25.41%
From $3.62 to $4.54 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

3.30 out of 5 stars

Medical Sector

8th out of 942 stocks

Surgical & Medical Instruments Industry

2nd out of 94 stocks


SWAV stock logo

About Shockwave Medical Stock (NASDAQ:SWAV)

ShockWave Medical, Inc., a medical device company, develops intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters for use in our IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter for use in IVL System in large diameter vessels. It also provides product for the treatment of coronary artery disease, such as C2 IVL catheter and C2+IVL catheter that are two-emitter catheters for use in IVL system. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.

SWAV Stock Price History

SWAV Stock News Headlines

Shockwave Medical: Optimal 2024 Setup For Gains
Lithium Discovery So BIG You Can't Miss it, Even From Space
With the green energy transition well underway, lithium demand is rapidly outpacing projected supply. While companies frantically search for new sources of this critical metal, one small company is sitting on a massive claim in North America - So big in fact that it can clearly be seen from space!
ShockWave Medical Inc SWAV
U.S. Military Defense Fails Without Vanadium?
The metal vanadium is needed for numerous military applications, including jet engines, airframes, and ballistic missiles. And although the U.S. Govt. considers vanadium critical to national security, less than 5% of the metal is mined in America. This means we're at the mercy of China and Russia for our supply.
Shockwave Medical: Buying The Dip
Shockwave Medical (SWAV) Q3 2023 Earnings Call Transcript
See More Headlines
Receive SWAV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Shockwave Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/06/2023
Today
12/10/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
2/15/2024

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SWAV
Fax
N/A
Employees
1,001
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$263.00
High Stock Price Target
$315.00
Low Stock Price Target
$218.00
Potential Upside/Downside
+51.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
10 Analysts

Profitability

Net Income
$216 million
Pretax Margin
24.35%

Debt

Sales & Book Value

Annual Sales
$489.73 million
Cash Flow
$6.13 per share
Book Value
$14.15 per share

Miscellaneous

Free Float
35,643,000
Market Cap
$6.43 billion
Optionable
Not Optionable
Beta
0.87
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives















SWAV Stock Analysis - Frequently Asked Questions

Should I buy or sell Shockwave Medical stock right now?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Shockwave Medical in the last twelve months. There are currently 2 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" SWAV shares.
View SWAV analyst ratings
or view top-rated stocks.

What is Shockwave Medical's stock price target for 2024?

10 brokers have issued 12-month price targets for Shockwave Medical's stock. Their SWAV share price targets range from $218.00 to $315.00. On average, they anticipate the company's share price to reach $263.00 in the next year. This suggests a possible upside of 51.0% from the stock's current price.
View analysts price targets for SWAV
or view top-rated stocks among Wall Street analysts.

How have SWAV shares performed in 2023?

Shockwave Medical's stock was trading at $205.61 on January 1st, 2023. Since then, SWAV shares have decreased by 15.3% and is now trading at $174.20.
View the best growth stocks for 2023 here
.

When is Shockwave Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 15th 2024.
View our SWAV earnings forecast
.

How were Shockwave Medical's earnings last quarter?

Shockwave Medical, Inc. (NASDAQ:SWAV) announced its earnings results on Monday, November, 6th. The company reported $0.92 EPS for the quarter, beating the consensus estimate of $0.81 by $0.11. The business earned $186.02 million during the quarter, compared to analyst estimates of $184.71 million. Shockwave Medical had a trailing twelve-month return on equity of 42.41% and a net margin of 36.33%. The firm's revenue for the quarter was up 41.6% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.92 earnings per share.

What is Doug Godshall's approval rating as Shockwave Medical's CEO?

8 employees have rated Shockwave Medical Chief Executive Officer Doug Godshall on Glassdoor.com. Doug Godshall has an approval rating of 89% among the company's employees.

What other stocks do shareholders of Shockwave Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Shockwave Medical investors own include NVIDIA (NVDA), Walt Disney (DIS), Block (SQ), Trade Desk (TTD), Salesforce (CRM), Roku (ROKU), PayPal (PYPL), DexCom (DXCM), Alibaba Group (BABA) and Okta (OKTA).

When did Shockwave Medical IPO?

(SWAV) raised $75 million in an initial public offering (IPO) on Thursday, March 7th 2019. The company issued 5,000,000 shares at $14.00-$16.00 per share. Morgan Stanley and BofA Merrill Lynch served as the underwriters for the IPO and Wells Fargo Securities and Canaccord Genuity were co-managers.

Who are Shockwave Medical's major shareholders?

Shockwave Medical's stock is owned by many different institutional and retail investors. Top institutional shareholders include FMR LLC (6.85%), Wellington Management Group LLP (4.89%), Artisan Partners Limited Partnership (3.80%), Invesco Ltd. (1.92%), Allspring Global Investments Holdings LLC (1.76%) and Morgan Stanley (1.17%). Insiders that own company stock include Antoine Papiernik, Colin Cahill, Dan Puckett, Douglas Evan Godshall, Frank T Watkins, Frank T Watkins, Isaac Zacharias, Kurt F Gallo, Laura Francis, Maria Sainz, Sara Toyloy and Trinh Phung.
View institutional ownership trends
.

How do I buy shares of Shockwave Medical?

Shares of SWAV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:SWAV) was last updated on 12/11/2023 by MarketBeat.com Staff

My Account -